Abstract
Cubosomes are self-assembled nanostructures that often form on dispersion of polar lipids in aqueous environments. The nanoparticles are analogous to liposomes but contain a complex internal self-assembled structure providing a point of difference to relatively simple liposomes. They exhibit a range of attractive properties such as having a high surface area, being able to incorporate both hydrophobic and hydrophilic molecules and controlled release. Consequently cubosomes are of increasing interest in fields such as drug delivery, and diagnostic imaging, in particular as a carrier for magnetic resonance imaging contrast agents. Over the last decade the incorporation of various contrast agents into the cubic mesophases has demonstrated improved relaxivity and resolution, as well as addressing other limitations of commercially available agents by increasing circulation time, stability and targeting. This minireview provides a brief overview of what cubosomes are, how they can be made, how they are characterised and also summarise the findings from the studies that have used cubosomes to develop better contrast agents for MRI, as well as highlight some potential for future developments.
Keywords: Cubosomes, cubic phase, MRI, contrast agent, relaxivity, liquid crystalline, lipid.
Current Medicinal Chemistry
Title:Cubosomes as Carriers for MRI Contrast Agents
Volume: 24 Issue: 5
Author(s): Nicolas Alcaraz and Ben J. Boyd
Affiliation:
Keywords: Cubosomes, cubic phase, MRI, contrast agent, relaxivity, liquid crystalline, lipid.
Abstract: Cubosomes are self-assembled nanostructures that often form on dispersion of polar lipids in aqueous environments. The nanoparticles are analogous to liposomes but contain a complex internal self-assembled structure providing a point of difference to relatively simple liposomes. They exhibit a range of attractive properties such as having a high surface area, being able to incorporate both hydrophobic and hydrophilic molecules and controlled release. Consequently cubosomes are of increasing interest in fields such as drug delivery, and diagnostic imaging, in particular as a carrier for magnetic resonance imaging contrast agents. Over the last decade the incorporation of various contrast agents into the cubic mesophases has demonstrated improved relaxivity and resolution, as well as addressing other limitations of commercially available agents by increasing circulation time, stability and targeting. This minireview provides a brief overview of what cubosomes are, how they can be made, how they are characterised and also summarise the findings from the studies that have used cubosomes to develop better contrast agents for MRI, as well as highlight some potential for future developments.
Export Options
About this article
Cite this article as:
Alcaraz Nicolas and Boyd J. Ben, Cubosomes as Carriers for MRI Contrast Agents, Current Medicinal Chemistry 2017; 24 (5) . https://dx.doi.org/10.2174/0929867323666160817141556
DOI https://dx.doi.org/10.2174/0929867323666160817141556 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunosuppressive Treatments in Acute Myocardial Infarction and Stroke
Current Pharmaceutical Biotechnology The Shift in the “Paradigm” of the Pharmacology of Hypertension
Current Topics in Medicinal Chemistry The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
Current Drug Targets Addressing Alzheimer’s Disease and Cognitive Loss through Autophagy
Current Neurovascular Research Cannabinoids and Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?
Current Pharmaceutical Design A Perspective on Clinical Islet Transplantation: Past, Present and Developments for Future
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Coronary No-Reflow Phenomenon in Clinical Practice
Current Pharmaceutical Design Lectin-Like Oxidized Low Density Lipoprotein Receptor 1 (LOX-1) in Atherogenesis: A Brief Review
Current Medicinal Chemistry Diabetic Cardiomyopathy and its Prevention by Metallothionein: Experimental Evidence, Possible Mechanisms and Clinical Implications
Current Medicinal Chemistry Neutrophil-Derived Cytokines: Potential Therapeutic Targets in Inflammation
Current Drug Targets - Inflammation & Allergy Structure, Function and Control of Complement C5 and its Proteolytic Fragments
Current Molecular Medicine Chagas Heart Disease Pathogenesis: One Mechanism or Many?
Current Molecular Medicine Perinatal Brain Injury
Current Pediatric Reviews PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders
Current Drug Delivery Proteomic Analysis of Liver Preservation Solutions Prior to Liver Transplantation
Current Proteomics NSE, S100B and MMP9 Expression Following Reperfusion after Carotid Artery Stenting
Current Neurovascular Research Inodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery
Current Vascular Pharmacology The Role of Dietary Polyphenols in the Management of Inflammatory Bowel Disease
Current Pharmaceutical Biotechnology Exosome Limitations in the Treatment of Inflammatory Diseases
Current Pharmaceutical Design